XML 35 R23.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment and Related Information
 6 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Segment and Related Information
(17) SEGMENT AND RELATED INFORMATION

The Company’s business is aligned with how the Chief Operating Decision Maker reviews performance and makes decisions in managing the Company. The business units have been aggregated into two reportable segments: (i) diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology.

Segment revenue and operating income (loss) were as follows during the periods presented:

 

     Diagnostics      Other      Total  

Three months ended December 31, 2016

         

Revenues

    $ 183.9       $ 12.6       $ 196.5   

Depreciation and amortization

      11.5         1.5         13.0   

Segment operating income (loss)

      32.1         (18.9 )       13.2   

Three months ended December 31, 2015

         

Revenues

    $ 182.6       $ 10.7       $ 193.3   

Depreciation and amortization

      5.5         1.3         6.8   

Segment operating income (loss)

      64.6         (19.4 )       45.2   

Six months ended December 31, 2016

         

Revenues

    $ 348.9       $ 25.0       $ 373.9   

Depreciation and amortization

      19.3         2.8         22.1   

Segment operating income (loss)

      63.1         (43.7 )       19.4   

Six months ended December 31, 2015

         

Revenues

    $ 354.5       $ 22.3       $ 376.8   

Depreciation and amortization

      10.9         2.6         13.5   

Segment operating income (loss)

      127.0         (38.5 )       88.5   

 

     Three months ended
December 31,		      Six months ended
December 31,		  
     2016      2015      2016      2015  

Total operating income for reportable segments

    $ 13.2       $ 45.2       $ 19.4       $ 88.5   

Unallocated amounts:

            

Interest income

      0.3         0.1         0.6         0.2   

Interest expense

      (2.6 )       (0.1 )       (3.3 )       (0.1 ) 

Other

      1.2         (0.2 )       (0.6 )       —     
  

 

 

     

 

 

     

 

 

     

 

 

  

Income from operations before income taxes

      12.1         45.0         16.1         88.6   
  

 

 

     

 

 

     

 

 

     

 

 

  

Income tax provision

      6.2         7.9         11.4         21.1   
  

 

 

     

 

 

     

 

 

     

 

 

  

Net income

    $ 5.9       $ 37.1       $ 4.7       $ 67.5